| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,§
*
Laboratory of Immunology, Gerontology Research Center, National Institute on Aging,
National Institutes of Health, Baltimore, MD 21224;
Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892; and
§
Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Age effects on telomere length and telomerase expression in peripheral blood lymphocytes were analyzed from 121 normal individuals age newborn to 94 years and revealed several new findings. 1) Telomere shortening was observed in CD4+ and CD8+ T and B cells with age. However, the rate of telomere loss was significantly different in these populations, 35 ± 8, 26 ± 7, and 19 ± 7 bp/year for CD4+ and CD8+ T and B cells, respectively. In addition, CD4+ T cells had the longest average telomeres at all ages, followed by B cells, with CD8+ T cell telomeres the shortest, suggesting that these lymphocyte populations may have different replicative histories in vivo. 2) Telomerase activity in freshly isolated T and B cells was indistinguishably low to undetectable at all ages but was markedly increased after Ag and costimulatory receptors mediated stimulation in vitro. Furthermore, age did not alter the magnitude of telomerase activity induced after stimulation of T or B lymphocytes through Ag and costimulatory receptors or in response to PMA plus ionomycin treatment. 3) The levels of telomerase activity induced by in vitro stimulation varied among individual donors but were highly correlated with the outcome of telomere length change in CD4+ T cells after Ag receptor-mediated activation. Together, these results indicate that rates of age-associated loss of telomere length in vivo in peripheral blood lymphocytes is specific to T and B cell subsets and that age does not significantly alter the capacity for telomerase induction in lymphocytes.
This article has been cited by other articles:
|
|
 |
|
  A. Aviv, A. M Valdes, and T. D Spector Human telomere biology: pitfalls of moving from the laboratory to epidemiology Int. J. Epidemiol., December 1, 2006; 35(6): 1424 - 1429. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Li, W. Zhi, P. Wareski, and N.-p. Weng IL-15 Activates Telomerase and Minimizes Telomere Loss and May Preserve the Replicative Life Span of Memory CD8+ T Cells In Vitro J. Immunol., April 1, 2005; 174(7): 4019 - 4024. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W Klapper, F Moosig, A Sotnikova, W Qian, J O Schroder, and R Parwaresch Telomerase activity in B and T lymphocytes of patients with systemic lupus erythematosus Ann Rheum Dis, December 1, 2004; 63(12): 1681 - 1683. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Wallace, Y. Zhang, H. Ghattas, A. Worth, A. Irvine, A. R. Bennett, G. E. Griffin, P. C. L. Beverley, D. F. Tough, and D. C. Macallan Direct Measurement of T Cell Subset Kinetics In Vivo in Elderly Men and Women J. Immunol., August 1, 2004; 173(3): 1787 - 1794. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Wulff, H.-G. Knaus, M. Pennington, and K. G. Chandy K+ Channel Expression during B Cell Differentiation: Implications for Immunomodulation and Autoimmunity J. Immunol., July 15, 2004; 173(2): 776 - 786. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Caporossi, G. Argentin, M. Pittaluga, P. Parisi, B. Tedeschi, P. Vernole, and R. Cicchetti Individual susceptibility to DNA telomerase inhibitors: a study on the chromosome instability induced by 3'-azido-3'-deoxythymidine in lymphocytes of elderly twins Mutagenesis, March 1, 2004; 19(2): 99 - 104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. N. Damle, F. M. Batliwalla, F. Ghiotto, A. Valetto, E. Albesiano, C. Sison, S. L. Allen, J. Kolitz, V. P. Vinciguerra, P. Kudalkar, et al. Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations Blood, January 15, 2004; 103(2): 375 - 382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Roth, H. Yssel, J. Pene, E. A. Chavez, M. Schertzer, P. M. Lansdorp, H. Spits, and R. M. Luiten Telomerase levels control the lifespan of human T lymphocytes Blood, August 1, 2003; 102(3): 849 - 857. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Luiten, J. Pene, H. Yssel, and H. Spits Ectopic hTERT expression extends the life span of human CD4+ helper and regulatory T-cell clones and confers resistance to oxidative stress-induced apoptosis Blood, June 1, 2003; 101(11): 4512 - 4519. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Cherif, J. L. Tarry, S. E. Ozanne, and C. N. Hales Ageing and telomeres: a study into organ- and gender-specific telomere shortening Nucleic Acids Res., March 1, 2003; 31(5): 1576 - 1583. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. C. Allsopp, S. Cheshier, and I. L. Weissman Telomerase Activation and Rejuvenation of Telomere Length in Stimulated T Cells Derived from Serially Transplanted Hematopoietic Stem Cells J. Exp. Med., December 2, 2002; 196(11): 1427 - 1433. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Johnson, S. J. Rozzo, and J. C. Cambier Aging-Dependent Exclusion of Antigen-Inexperienced Cells from the Peripheral B Cell Repertoire J. Immunol., May 15, 2002; 168(10): 5014 - 5023. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N.-p. Weng Interplay between telomere length and telomerase in human leukocyte differentiation and aging J. Leukoc. Biol., December 1, 2001; 70(6): 861 - 867. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. S. J. Elenitoba-Johnson Complex Regulation of Telomerase Activity : Implications for Cancer Therapy Am. J. Pathol., August 1, 2001; 159(2): 405 - 410. [Full Text]
|
|
|
|
 |
|
 A. Aviv Hypothesis : Pulse Pressure and Human Longevity Hypertension, April 1, 2001; 37(4): 1060 - 1066. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
